Catheter Precision (VTAK) Operating Income (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Operating Income data on file, last reported at -$2.3 million in Q1 2026.

• Operating Income for Q1 2026 came in at -$2.3 million, up 35.16% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (up 76.73% YoY), and the FY2025 annual result was -$4.1 million, up 63.57% from the prior year.
• Operating Income retreated to -$2.3 million in Q1 2026 per VTAK's latest filing, from $7.2 million in the prior quarter.
• Over five years, Operating Income peaked at $7.2 million in Q4 2025 and troughed at -$66.5 million in Q1 2023.
• A 5-year average of -$7.2 million and a median of -$3.1 million in 2024 frame the typical range for Operating Income.
• The sharpest annual moves came in 2023 and 2025: Operating Income sank 1108.14% in 2023, then surged 335.53% in 2025.
• A 5-year view of Operating Income shows it stood at -$8.2 million in 2022, then soared by 68.39% to -$2.6 million in 2023, then declined by 17.48% to -$3.1 million in 2024, then surged by 335.53% to $7.2 million in 2025, then slumped by 132.26% to -$2.3 million in 2026.
• Business Quant data shows VTAK's Operating Income at -$2.3 million in Q1 2026, $7.2 million in Q4 2025, and -$3.0 million in Q3 2025.